The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review
Reviews in Cardiovascular Medicine · 18.12.2025 · 26 (12)
DOI: 10.31083/rcm45204 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 18.12.2025. Verfasst von Dhir Gala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertension is a prominent cardiovascular risk factor, especially among patients with diabetes and obesity. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of drugs originally developed to improve glycemic control in patients with diabetes; however, these agonists have subsequently demonstrated additional cardioprotective effects, including modest reductions in blood pressure (BP). This literature review examines the various mechanisms through which GLP-1 RAs reduce BP, including weight loss, improved endothelial function, and renal sodium management. While GLP-1 RAs are less potent in BP reduction compared to conventional antihypertensive agents, the broader metabolic benefits of these agonists make this class of drug a valuable adjunct in managing hypertension, particularly in patients with metabolic syndrome. Nonetheless, further studies are needed to explore the long-term effects of BP and optimize patient selection for maximal cardiovascular benefit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
- Department of Cardiology, Cardiovascular Institute, Northwell Health, New Hyde Park, NY 11040, USA.
- Department of Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.
ORCID-Profile: Dhir Gala, Fady Botros, Amgad N Makaryus
Zitieren
APA
Gala, D., Botros, F., & Makaryus, A. N. (2025). The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review. Reviews in Cardiovascular Medicine, 26(12). https://doi.org/10.31083/rcm45204
Vancouver
Gala D, Botros F, Makaryus AN. The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review. Reviews in Cardiovascular Medicine. 2025;26(12). doi:10.31083/rcm45204
BibTeX
@article{Gala2025,
author = {Gala, Dhir and Botros, Fady and Makaryus, Amgad N},
title = {The Beneficial Effects of Glucagon-Like Peptide-1 Agonists on Blood Pressure: A Comprehensive Review},
journal = {Reviews in Cardiovascular Medicine},
year = {2025},
volume = {26},
number = {12},
doi = {10.31083/rcm45204}
}
EUVIMED